Medications That Can Cause Priapism and Their Mechanisms
Several commonly used medications can cause priapism, with alpha-adrenergic blockers, antipsychotics, and erectile dysfunction drugs being the most frequent culprits. 1, 2
Definition and Types of Priapism
Priapism is a persistent penile erection that continues for more than 4 hours beyond, or unrelated to, sexual stimulation. It is a urological emergency that requires prompt evaluation and management. 1
There are three main types:
Ischemic (veno-occlusive, low flow) priapism: A non-sexual, painful persistent erection with little or no cavernous blood flow and abnormal blood gases (hypoxic, hypercarbic, acidotic). The corpora cavernosa are rigid and tender. This is a true emergency. 1
Non-ischemic (arterial, high flow) priapism: A persistent erection caused by unregulated cavernous arterial inflow. The penis is typically neither fully rigid nor painful. Often associated with trauma. 1
Stuttering (intermittent) priapism: Recurrent episodes of ischemic priapism with periods of detumescence in between. 1
Medications Associated with Priapism
1. Erectile Dysfunction Medications
- PDE-5 Inhibitors (sildenafil, tadalafil, vardenafil)
- Mechanism: Inhibit phosphodiesterase type 5, preventing breakdown of cGMP, leading to prolonged smooth muscle relaxation and increased blood flow 1, 3
- Risk factors: Anatomical deformation of the penis, sickle cell anemia, multiple myeloma, leukemia 3
- Incidence: Reported infrequently during post-marketing surveillance 1
2. Psychotropic Medications
Antipsychotics (both typical and atypical)
Antidepressants (particularly trazodone)
3. Antihypertensives
- Alpha-blockers (particularly prazosin)
4. Other Medications
- Anticoagulants (particularly heparin) 2
- Intracavernosal injection therapies for erectile dysfunction (papaverine, phentolamine, alprostadil) 1, 8
- Highest incidence: 1.4% of patients using intracavernosal drugs reported priapism events in one study 8
Pathophysiological Mechanism
The primary mechanism for drug-induced priapism involves:
Alpha-adrenergic blockade: Most implicated drugs have alpha-adrenergic blocking properties that interfere with the normal detumescence mechanism 2, 4
Normal erection physiology: Erection involves relaxation of smooth muscles in the corpora cavernosa and increased arterial blood flow. Detumescence requires sympathetic nervous system activation via alpha-adrenergic receptors 1, 2
Disrupted detumescence: When drugs block alpha-adrenergic receptors, the normal detumescence mechanism fails, leading to persistent erection 2, 4
Risk Factors and Prevention
Pre-existing conditions that increase risk: Sickle cell anemia, leukemia, multiple myeloma, anatomical deformation of the penis 3, 7
Drug combinations: Risk may increase when combining medications with alpha-blocking properties or adding new drugs to an existing regimen 4
Patient education: Informing patients about this potential side effect is crucial for early reporting and treatment 4, 5
Clinical Implications
Medical emergency: Ischemic priapism requires immediate treatment to prevent permanent erectile dysfunction 1, 9
Treatment approach:
Medication selection: For patients with a history of priapism, consider medications with lower alpha-adrenergic blocking properties (e.g., amisulpride has been suggested as an alternative antipsychotic with minimal alpha-adrenergic affinity) 5
Key Takeaways
Drug-induced priapism accounts for approximately 30% of all priapism cases 2
Alpha-adrenergic blockade is the primary mechanism for most drug-induced priapism 2, 4
Priapism is a urological emergency requiring prompt intervention to prevent permanent erectile dysfunction 1, 9
Patient education and awareness are essential for early reporting and treatment 4, 5